Armistice Capital, LLC Bluebird Bio, Inc. Transaction History

Armistice Capital, LLC

$6.02 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.07 - $10.6 $9.56 Million - $24.9 Million	-2,348,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $1.11 Million - $2.02 Million	-124,000 Reduced 5.02%	2,348,000 $23.5 Million
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $7.15 Million - $13.4 Million	636,000 Added 34.64%	2,472,000 $47.2 Million
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $2.31 Million - $2.83 Million	-128,000 Reduced 6.52%	1,836,000 $58.7 Million
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $18 Million - $36.8 Million	1,086,000 Added 123.69%	1,964,000 $59.2 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $2.15 Million - $2.96 Million	78,000 Added 9.75%	878,000 $38 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $43.75 $7.99 Million - $10.2 Million	232,000 Added 40.85%	800,000 $43.2 Million
Q2 2020 Aug 14, 2020	SELL	$27.12 - $45.97 $2.17 Million - $3.68 Million	-80,000 Reduced 12.35%	568,000 $34.7 Million
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $8.16 Million - $19.8 Million	312,000 Added 92.86%	648,000 $29.8 Million
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $15.8 Million - $20.7 Million	336,000 New	336,000 $29.5 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $5.95 Million - $9.31 Million	-100,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $2.43 Million - $3.37 Million	32,000 Added 47.06%	100,000 $12.7 Million
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $4.38 Million - $7.08 Million	68,000 New	68,000 $10.7 Million
Q4 2018 Feb 14, 2019	SELL	$59.1 - $93.26 $5.2 Million - $8.21 Million	-88,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $8.18 Million - $10.8 Million	-92,000 Reduced 51.11%	88,000 $12.8 Million
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $12 Million - $15.3 Million	120,000 Added 200.0%	180,000 $28.3 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $2.65 Million - $3.77 Million	25,000 Added 71.43%	60,000 $10.2 Million
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $243,750 - $392,099	-3,000 Reduced 7.89%	35,000 $6.23 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $2.19 Million - $3.47 Million	38,000	38,000 $5.22 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.67 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.64 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.63 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.34 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account